Jardiance® Tablets for Type 2 Diabetes and Heart Failure

What Jardiance® Is and How It Works

Jardiance® (empagliflozin) is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is used for adults with type 2 diabetes to improve blood sugar control, and to reduce the risk of cardiovascular death and hospitalization in heart failure. It is also studied for kidney protection in chronic kidney disease. Tablets are available in 10 mg and 25 mg strengths taken once daily. Jardiance price and Jardiance cost vary by strength and pack size, and many patients compare Jardiance 10 mg and 25 mg options before ordering.

YouDrugstore is a licensed Canadian pharmacy headquartered in Manitoba, and licensed pharmacists review every prescription before dispensing. We also source through vetted international partner pharmacies, offering authentic brand medicines across a broad range at affordable prices.

Empagliflozin blocks SGLT2 in the proximal renal tubules. This reduces glucose reabsorption, increases urinary glucose excretion, and lowers plasma glucose independent of insulin. The medicine can also modestly reduce weight and systolic blood pressure by promoting osmotic diuresis and natriuresis. In heart failure, these effects support decongestion and improve outcomes across ejection-fraction ranges, whether or not diabetes is present.

Dosage and Usage

• Usual start for type 2 diabetes: 10 mg orally once daily, with or without food.
• May increase to 25 mg once daily if more glycemic lowering is needed and tolerated.
• Heart failure (with or without diabetes): 10 mg once daily is standard; higher doses are not required for HF outcomes.
• Chronic kidney disease: commonly 10 mg once daily; glycemic effect declines at low eGFR, but cardiorenal benefits may remain.
• Swallow tablets whole with water. Morning dosing is common due to diuretic effects.
• Missed dose: take when remembered the same day; skip if near the next dose. Do not double doses.
• Hold for at least 3 days before major surgery or prolonged fasting to reduce ketoacidosis risk.
• Hydration matters. Volume depletion can increase dizziness or low blood pressure, especially with diuretics.
• Renal function may guide initiation and ongoing use. Dialysis is a contraindication.

• Store at 15–30 °C (59–86 °F) in a dry place. Keep the bottle tightly closed.
• Keep out of reach of children and pets. Do not use past expiration.
• For travel, keep your tablets in carry-on luggage with a copy of your prescription.
• Avoid heat and moisture (bathrooms, parked cars). Use a travel pill case that stays dry.
• Bring extra doses for delays and a list of your medications.

Benefits and Savings

Jardiance uses span glucose control, cardiorenal protection, and convenience. Once-daily tablets support adherence. Many patients see A1C reductions of about 0.5–1.0% and modest weight loss. Heart failure trials show lower hospitalization risk and cardiovascular death benefits across ejection fractions. Blood pressure typically falls by a few millimeters of mercury.

Ordering Jardiance online from Canadian pharmacies can offer significant value. Typical customers save 60–80% versus usual US retail prices. Jardiance 10 mg price and 25 mg price differ by strength and pack count. Multi-month supplies can reduce the per-month cost, and periodic bulk promotions may further lower spend. You can also set gentle reorder reminders so refills never sneak up.

Jardiance coupon availability may change; check the promotions page for current offers. Customers also watch for a Jardiance discount during seasonal sales.

Side Effects and Safety

• Genital yeast infections (more common in females and uncircumcised males)
• Urinary tract infections and increased urination
• Thirst, dry mouth, and mild dehydration
• Nausea or stomach discomfort
• Dizziness or low blood pressure, especially in volume depletion
• Modest increases in LDL cholesterol

Serious but uncommon risks include ketoacidosis (which can occur even with near-normal glucose), severe urinary infections (pyelonephritis, urosepsis), acute kidney injury, and rare necrotizing fasciitis of the perineum (Fournier’s gangrene). Allergic reactions can occur. The risk of hypoglycemia increases when empagliflozin is combined with insulin or sulfonylureas; those doses may need adjustment to reduce low blood sugar.

Onset Time

Urinary glucose excretion increases after the first dose, and fasting glucose often improves within days. A1C changes become clear over 8–12 weeks as steady use continues. Diuretic effects, such as more frequent urination or slight weight changes, can appear within the first week. Heart failure outcomes improve over weeks to months as congestion and cardiac stress decrease.

Compare With Alternatives

Other SGLT2 inhibitors, such as dapagliflozin and canagliflozin, offer similar glucose and heart failure benefits. Differences include approved indications, renal thresholds, and adverse-event profiles (for example, amputation risk was highlighted with canagliflozin).

DPP-4 inhibitors provide glucose lowering without diuresis or weight loss. Sitagliptin is a common choice; see Januvia® for details. DPP-4 agents do not deliver the same heart failure or kidney-protection outcomes seen with SGLT2 inhibitors.

For heart failure with reduced or preserved ejection fraction, guideline-directed therapy often includes ARNI, beta-blockers, MRAs, and SGLT2 inhibitors. An ARNI option is Entresto®, which complements empagliflozin by reducing neurohormonal stress and afterload.

Combination Therapy

• Metformin plus empagliflozin for additive glucose lowering and weight neutrality or loss.
• GLP-1 receptor agonists combined with SGLT2 inhibitors for greater A1C and weight effects.
• DPP-4 inhibitors are sometimes used when GLP-1 injections are not preferred.
• Insulin or sulfonylureas may require dose reductions to lower hypoglycemia risk when starting an SGLT2 inhibitor.
• Heart failure regimens: ARNI/ACEi/ARB, beta-blocker, MRA, loop diuretic, and empagliflozin; monitor volume status.

Patient Suitability and Cost-Saving Tips

Jardiance medication is intended for adults with type 2 diabetes, and for adults with heart failure irrespective of diabetes status. It is not indicated for type 1 diabetes. Glycemic efficacy falls as eGFR declines, but cardiorenal benefits may persist into lower eGFR ranges. Do not use during dialysis. Pause before major surgery or prolonged fasting to reduce ketoacidosis risk. Pregnancy (particularly second and third trimesters) and breastfeeding are generally not recommended. People with recurrent genital infections, severe dehydration, or a history of hypersensitivity need careful assessment.

There is currently no widely marketed generic of Jardiance in Canada. Patients often compare Jardiance online with other therapies when discussing coverage or budgeting. Pricing is straightforward, and many customers plan 90-day supplies to lower the monthly spend. Reorder reminders help prevent gaps in therapy. Buying together with other maintenance medicines can reduce shipping cost per item.

Jardiance cost can differ by strength. The 10 mg and 25 mg tablets are priced separately, and pack sizes may change the per-tablet price. Patients who compare options sometimes find a better overall value by selecting multi-pack orders during a promotion.

Authoritative Sources

FDA Prescribing Information for Empagliflozin

Health Canada Drug Product Database: Empagliflozin

Manufacturer Product Information for Jardiance

Order Jardiance® from Youdrugstore: add to cart, upload your prescription, and we ship with prompt, express shipping.

This material is educational and does not replace medical advice. Speak with a licensed healthcare professional about diagnosis, treatment choices, and risks for your situation.